CClinicalTrials.gg
Status unknownNCT02983955UPNRIDE_SAFEUpdated Dec 6, 2016

UPNRIDE Powered Wheelchair for Individuals With Walking Impairment: Evaluation of Safety and Usability

An interventional study of UPnRIDE Powered Wheelchair in Spinal Cord Injury Cervical, sponsored by UPnRIDE Robotics Ltd.. Status unknown at 1 site in Israel. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2016-12-06.

Sponsored by UPnRIDE Robotics Ltd. · Not applicable and Interventional

The sponsor has not verified this record recently (last verified Dec 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The UPnRIDE Powered Wheelchair device is a product which changes people position from sitting to standing and standing to sitting. The product provides indoor and outdoor mobility.

The main purpose of this study is to evaluate the safety of the UPnRIDE powered wheelchair as an outdoor and indoor mobility device by individuals with walking impairment.

Read the detailed description

A new powered wheelchair has recently been developed to address the ability of the user to be able to position them in an upright, standing position. This new device is called the UPnRIDE powered wheelchair and is different from other upright wheelchairs because current standing wheelchair models have limited mobility in the standing position. The UPnRIDE is an upright or seated mobility device that is intended to provide full upright standing posture in a mobile powered wheelchair. The UPnRIDE powered wheelchair provides wheelchair and scooter users the ability to engage in society in either a standing (upright mobility) or seated position (seated mobility). Additionally, the option to have upright posture throughout the day may have the potential to improve some of the secondary medical conditions associated with the extreme sedentary lifestyle that paralysis from SCI imposes. This wheeled, motorized device can provide mobility to most urban environment situations by being able to be navigated indoors and outdoors and over different surfaces in both the standing or seated positions.

02

Conditions studied

  • Spinal Cord Injury Cervical
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's planned enrollment of 15 is below the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

This is the only study on the registry with UPnRIDE Robotics Ltd. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria

  1. Males and non-pregnant, non-lactating females
  2. Ages 18-70
  3. Suffered from a SCI which caused Tetraplegia, ASIA A-B-C
  4. At least 1 year after SCI
  5. Height of 155 to 190 cm;
  6. Weight less than 100 kg
  7. Able to sign informed consent.
  8. Power or manual wheelchair user as a primary means of mobility
  9. Regular user of a standing frame or tilt table for at least 30 minutes a week Exclusion Criteria
  1. History of severe neurological disorder other than SCI (multiple sclerosis, cerebral palsy, amyotrophic lateral sclerosis, traumatic brain injury, stroke, etc.) 2. Concurrent severe medical disease 3. Pressure sores 4. Unstable spine 5. Unhealed limb or pelvic fractures 6. Psychiatric or cognitive status that may interfere with the trial
05

Study design

Phase
Not applicable
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Other
    SCI with Tetraplegia

    Device: UPnRIDE Powered Wheelchair

Interventions

  • DeviceUPnRIDE Powered Wheelchair

    The UPnRIDE Powered Wheelchair device is a product which changes people position from sitting to standing and standing to sitting. The product provides indoor and outdoor mobility.

06

What researchers measure

Primary outcomes

  1. Adverse events

    Time frame: Through study completion, an average of 3 months

Secondary outcomes

  1. Successes rate of task performance

    Study success is defined if 70% of study subjects are defined success

    Time frame: Through study completion, an average of 3 months

07

Study locations

1 of 1 sites recruiting
  • The Chaim Sheba Medical Center
    Ramat Gan, Israel
    • Amihai Gottlieb · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02983955
Lead sponsor
UPnRIDE Robotics Ltd.
Collaborators
Sheba Medical Center
Responsible party
Sponsor
First posted
Dec 6, 2016
Start date
Nov 2016
Primary completion
Dec 2016 (estimated)
Completion
Jan 2017 (estimated)
Last update
Dec 6, 2016

Study contacts

Shany Kheifets-Zohar, Bsc.
Contact
shany@upnride.com
972-4-6110061
Gabi Zeilig, MD
principal investigator · Department of Neurological Rehabilitation The Chaim Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine,

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion